PMID- 10206644 OWN - NLM STAT- MEDLINE DCOM- 19990428 LR - 20220331 IS - 0028-0836 (Print) IS - 0028-0836 (Linking) VI - 398 IP - 6727 DP - 1999 Apr 8 TI - Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. PG - 513-7 AB - Accumulation of the amyloid-beta protein (Abeta) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease. The final step in the generation of Abeta from the beta-amyloid precursor protein is an apparently intramembranous proteolysis by the elusive gamma-secretase(s). The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters gamma-secretase activity to increase the production of the highly amyloidogenic Abeta42 isoform. Moreover, deletion of presenilin-1 in mice greatly reduces gamma-secretase activity, indicating that presenilin-1 mediates most of this proteolytic event. Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Abeta production and increases the amounts of the carboxy-terminal fragments of beta-amyloid precursor protein that are the substrates of gamma-secretase. We observed these effects in three different cell lines as well as in cell-free microsomes. Either of the Asp --> Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 --> TM7 cytoplasmic loop. In a functional presenilin-1 variant (carrying a deletion in exon 9) that is associated with familial Alzheimer's disease and which does not require this cleavage, the Asp 385 --> Ala mutation still inhibited gamma-secretase activity. Our results indicate that the two transmembrane aspartate residues are critical for both presenilin-1 endoproteolysis and gamma-secretase activity, and suggest that presenilin 1 is either a unique diaspartyl cofactor for gamma-secretase or is itself gamma-secretase, an autoactivated intramembranous aspartyl protease. FAU - Wolfe, M S AU - Wolfe MS AD - Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. mwolfe@utmem.edu FAU - Xia, W AU - Xia W FAU - Ostaszewski, B L AU - Ostaszewski BL FAU - Diehl, T S AU - Diehl TS FAU - Kimberly, W T AU - Kimberly WT FAU - Selkoe, D J AU - Selkoe DJ LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Nature JT - Nature JID - 0410462 RN - 0 (Amyloid beta-Peptides) RN - 0 (Amyloid beta-Protein Precursor) RN - 0 (Coenzymes) RN - 0 (Membrane Proteins) RN - 0 (PSEN1 protein, human) RN - 0 (Peptide Fragments) RN - 0 (Presenilin-1) RN - 0 (Recombinant Proteins) RN - 30KYC7MIAI (Aspartic Acid) RN - EC 3.4.- (Amyloid Precursor Protein Secretases) RN - EC 3.4.- (Endopeptidases) RN - EC 3.4.23.- (Aspartic Acid Endopeptidases) RN - EC 3.4.23.46 (BACE1 protein, human) SB - IM CIN - Nature. 1999 Apr 8;398(6727):466-7. PMID: 10206639 MH - Alzheimer Disease/metabolism MH - Amyloid Precursor Protein Secretases MH - Amyloid beta-Peptides/*metabolism MH - Amyloid beta-Protein Precursor/metabolism MH - Animals MH - Aspartic Acid/*metabolism MH - Aspartic Acid Endopeptidases/metabolism MH - CHO Cells MH - COS Cells MH - Cell Line MH - Cell Membrane/metabolism MH - Cell-Free System MH - Coenzymes/metabolism MH - Cricetinae MH - Electrochemistry MH - Endopeptidases/*metabolism MH - Exons MH - Humans MH - Membrane Proteins/chemistry/genetics/*metabolism MH - Microsomes/metabolism MH - Mutagenesis, Site-Directed MH - Peptide Fragments/metabolism MH - Presenilin-1 MH - Protein Folding MH - Recombinant Proteins/metabolism MH - Transfection EDAT- 1999/04/17 02:16 MHDA- 2001/03/23 10:01 CRDT- 1999/04/17 02:16 PHST- 1999/04/17 02:16 [pubmed] PHST- 2001/03/23 10:01 [medline] PHST- 1999/04/17 02:16 [entrez] AID - 10.1038/19077 [doi] PST - ppublish SO - Nature. 1999 Apr 8;398(6727):513-7. doi: 10.1038/19077.